Press Releases, Pharmaceutical

Aptar Pharma Acquires the Assets of Cohero Health, a Digital Respiratory Health Company

Investment further expands Aptar Pharma’s global capabilities in digital health.

4 Nov 2020

AptarGroup, Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions and services, announces that it has acquired all operating assets and the proprietary portfolio of Cohero Health, Inc. (“Cohero Health”), a digital therapeutics company transforming respiratory disease management for asthma and chronic obstructive pulmonary disorder (COPD).

Founded in 2013, New York-based Cohero Health develops innovative digital tools and technologies to improve respiratory care, reduce avoidable costs and optimize medication utilization.  With this transaction, Aptar Pharma acquires Cohero Health’s turnkey digital health platform and device assets including their BreatheSmart® Connect digital health platform, their BreatheSmart® App, their HeroTracker® Sensors, and theirSpirometer™ and cSpirometer™lung function diagnostic sensors.

Adding digital solutions to current treatments and therapies provides a mechanism for patients and health care providers to better manage disease conditions by providing seamless integration between disease management solutions and therapies.

“Cohero Health further strengthens and expands Aptar’s digital portfolio, in this case, with a focus in respiratory disease management,” commented Sai Shankar, Aptar Pharma’s Vice President, Global Digital Healthcare Systems. “Aptar has made previous investments in other digital respiratory companies such as Sonmol in China and Navia Life Care in India. With this strategic bolt on, Aptar now has global capabilities to deploy digital respiratory health, utilizing either the Cohero or Aptar device portfolio/platform. The investment will also facilitate Aptar’s ability to provide diagnostic solutions in respiratory and a significant number of other disease categories.”

“Cohero and Aptar are simply a great fit presenting a unique opportunity to leverage the complementary strengths of both companies. Building on our robust platform and rich innovations, we expect this combination to position us to lead the way in delivering on our joint vision, developing digital therapeutics that provide patients a better future and bring our customers stability and greater breadth of digital tools, actionable data, services and solutions,” said Joe Condurso, Chief Executive Officer, Cohero Health, who will join Aptar Pharma. “I want to recognize and thank the Cohero Health team, and express deep gratitude to each of them for their many contributions over the years, which have enabled us to carry on the vision and mission to transform respiratory care.”

Gael Touya, President of Aptar Pharma, added, “We are pleased to welcome the Cohero Health team to the Aptar Pharma family. The combination of Aptar and Cohero Health will bring additional value to our pharmaceutical customers as they seek to put more life-changing respiratory treatments and tools into the hands of empowered patients. Together, we will work toward the ultimate goal of improving patient experiences and health outcomes.”

Download full press release here.

 

 

Back To Top